<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>HB 318 (Edition 1)</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Times New \(W1\)";}
@font-face
	{font-family:IDAutomationHC39M;
	panose-1:2 0 5 9 0 0 0 2 0 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.25pt;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:23.75pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.MsoLineNumber
	{font-family:"Times New Roman",serif;}
p.LMSBase, li.LMSBase, div.LMSBase
	{mso-style-name:LMSBase;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticle, li.aArticle, div.aArticle
	{mso-style-name:aArticle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticleTitle, li.aArticleTitle, div.aArticleTitle
	{mso-style-name:aArticleTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBase, li.aBase, div.aBase
	{mso-style-name:aBase;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBillSection, li.aBillSection, div.aBillSection
	{mso-style-name:aBillSection;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock1, li.aBlock1, div.aBlock1
	{mso-style-name:aBlock1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock2, li.aBlock2, div.aBlock2
	{mso-style-name:aBlock2;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock3, li.aBlock3, div.aBlock3
	{mso-style-name:aBlock3;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock4, li.aBlock4, div.aBlock4
	{mso-style-name:aBlock4;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock5, li.aBlock5, div.aBlock5
	{mso-style-name:aBlock5;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aChapter, li.aChapter, div.aChapter
	{mso-style-name:aChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aHeading, li.aHeading, div.aHeading
	{mso-style-name:aHeading;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aLongTitle, li.aLongTitle, div.aLongTitle
	{mso-style-name:aLongTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;}
p.aMargin1, li.aMargin1, div.aMargin1
	{mso-style-name:aMargin1;
	mso-style-link:"aMargin1 Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aMargin2, li.aMargin2, div.aMargin2
	{mso-style-name:aMargin2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aPart, li.aPart, div.aPart
	{mso-style-name:aPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSection, li.aSection, div.aSection
	{mso-style-name:aSection;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSP, li.aSP, div.aSP
	{mso-style-name:aSP;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;
	font-weight:bold;}
p.aSPComment, li.aSPComment, div.aSPComment
	{mso-style-name:aSPComment;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	color:red;
	display:none;
	font-weight:bold;}
p.aSPFunds1, li.aSPFunds1, div.aSPFunds1
	{mso-style-name:aSPFunds1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFunds2, li.aSPFunds2, div.aSPFunds2
	{mso-style-name:aSPFunds2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFundsHeading1, li.aSPFundsHeading1, div.aSPFundsHeading1
	{mso-style-name:aSPFundsHeading1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPFundsHeading2, li.aSPFundsHeading2, div.aSPFundsHeading2
	{mso-style-name:aSPFundsHeading2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPHeading, li.aSPHeading, div.aSPHeading
	{mso-style-name:aSPHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.nonumber, li.nonumber, div.nonumber
	{mso-style-name:nonumber;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPHeadingLine, li.aSPHeadingLine, div.aSPHeadingLine
	{mso-style-name:aSPHeadingLine;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.ASPlist, li.ASPlist, div.ASPlist
	{mso-style-name:ASPlist;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.5in;
	margin-bottom:.0001pt;
	text-indent:-1.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPRequestedBY, li.aSPRequestedBY, div.aSPRequestedBY
	{mso-style-name:aSPRequestedBY;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";}
p.aSPTitle, li.aSPTitle, div.aSPTitle
	{mso-style-name:aSPTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;
	font-weight:bold;}
p.aSubChapter, li.aSubChapter, div.aSubChapter
	{mso-style-name:aSubChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSubPart, li.aSubPart, div.aSubPart
	{mso-style-name:aSubPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aTitle, li.aTitle, div.aTitle
	{mso-style-name:aTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.cHistoryNote
	{mso-style-name:cHistoryNote;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
p.TOCPageHeader, li.TOCPageHeader, div.TOCPageHeader
	{mso-style-name:TOCPageHeader;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPSubTitle, li.aSPSubTitle, div.aSPSubTitle
	{mso-style-name:aSPSubTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPHeadingMiscellaneous, li.aSPHeadingMiscellaneous, div.aSPHeadingMiscellaneous
	{mso-style-name:aSPHeadingMiscellaneous;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aDistrict, li.aDistrict, div.aDistrict
	{mso-style-name:aDistrict;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.aMargin1Char
	{mso-style-name:"aMargin1 Char";
	mso-style-link:aMargin1;
	font-family:"Times New Roman",serif;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:10.0pt;
	line-height:115%;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 11.0in;
	margin:.6in .9in .5in 1.2in;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=nonumber align=center style='margin-top:24.0pt;text-align:center'><b>GENERAL
ASSEMBLY OF NORTH CAROLINA</b></p>

<p class=nonumber align=center style='margin-top:3.0pt;margin-right:0in;
margin-bottom:6.0pt;margin-left:0in;text-align:center'><b>SESSION 2019</b></p>

<p class=nonumber align=left style='text-align:left'><b>H                                                                                                                                                    1</b></p>

<p class=nonumber align=center style='text-align:center'><b>HOUSE BILL 318</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=0
 style='width:6.55in;margin-left:-5.75pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=527 colspan=2 valign=top style='width:395.25pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-bottom:6.0pt;text-align:left'>Short
  Title:      Opioid Prescription &amp; Treatment Opt Out Act.</p>
  </td>
  <td width=102 valign=top style='width:76.35pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=right style='margin-bottom:6.0pt;text-align:right'>(Public)</p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Sponsors:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Representatives Belk,
  Black, Dobson, and White (Primary Sponsors).</p>
  <p class=nonumber align=center style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:center'><i><span
  style='font-size:10.0pt'>For a complete list of sponsors, refer to the North
  Carolina General Assembly web site.</span></i></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Referred to:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber style='margin-top:3.0pt;margin-right:0in;margin-bottom:
  3.0pt;margin-left:0in'>Health, if favorable, Insurance, if favorable, Rules,
  Calendar, and Operations of the House</p>
  </td>
 </tr>
 <tr height=0>
  <td width=96 style='border:none'></td>
  <td width=431 style='border:none'></td>
  <td width=102 style='border:none'></td>
 </tr>
</table>

<p class=nonumber align=center style='margin-top:6.0pt;margin-right:0in;
margin-bottom:12.0pt;margin-left:0in;text-align:center'>March 12, 2019</p>

<p class=aBase align=center style='text-align:center'><span style='color:black'>A
BILL TO BE ENTITLED</span></p>

<p class=aLongTitle><span style='font-family:"Times New Roman",serif;
color:black'>AN ACT establishing the right of patients to elect nonopioid
prescriptions and treatment, establishing a process by which patients may opt
out of opioid prescriptions and treatment, and requiring the department of
health and human services to develop and make available on its internet web
site an official form for patients to voluntarily opt out of opioid
prescriptions and treatment.</span></p>

<p class=aBase><span style='color:black'>The General Assembly of North Carolina
enacts:</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 1.</span></b><span
style='color:black'>  This act shall be known and may be cited as &quot;The
Opioid Prescription and Treatment Opt Out Act.&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.</span></b><span
style='color:black'>  Article 1B of Chapter 90 of the General Statutes is
amended by adding a new section to read:</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;21.17A.  Portable voluntary nonopioid advance
directives; official form.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Legislative Intent. – It is the intent of the
General Assembly to recognize the desire and right of a patient to elect nonopioid
prescriptions and treatment. This section establishes an optional and
nonexclusive procedure by which a patient or the patient's representative may
exercise this right.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Definitions. – The following definitions apply
in this section:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Authorized practitioner. – A physician,
physician assistant, or nurse practitioner licensed and in good standing in
this State.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Patient's representative. – In the case of a
minor, a parent with custody of the minor or the legal guardian or legal
custodian of the minor. In all other cases, a legal guardian, or a health care
agent as defined in G.S.&nbsp;32A&#8209;16.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Consent and Procedures for Documenting Patient
Opt Out. – An authorized practitioner may issue a portable voluntary nonopioid
advance directive form for a patient with consent obtained as follows:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>With the consent of the patient, if the patient
is a competent adult.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>With the consent of the patient's parent, legal guardian,
or legal custodian, if the patient is a minor.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>With the consent of the patient's
representative, if the patient is not a minor but is incapable of making an
informed decision regarding consent for the opt out</u>.</span></p>

<p class=aMargin1><u><span style='color:black'>The authorized practitioner
shall document the basis for the portable voluntary nonopioid advance directive
form in the patient's medical record. Both the authorized practitioner or the
authorized practitioner's designee and the patient or the patient's
representative shall sign the form. The patient or the patient's representative
shall sign the original form in the presence of the physician or the physician's
designee, whether in paper or electronic form, and the signed form shall be
placed in the patient's medical record. When the signature of the patient or
the patient's representative is on a separate copy of the form, the original
form must indicate in the appropriate signature field that the signature is &quot;on
file.&quot;</span></u></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>Official Voluntary Nonopioid Advance Directive
Form. – The Department shall, in consultation with the North Carolina Medical
Board and the North Carolina Board of Pharmacy, develop and update, as
necessary, an official voluntary nonopioid advance directive form that
indicates to all health care providers that the named patient shall not be
offered, prescribed, supplied with, or otherwise administered a controlled
substance containing an opioid. The Department shall provide notification and a
copy of the form, as well as any subsequent updates to the form, to the
Commission for Mental Health, Developmental Disabilities, and Substance Abuse
Services. In addition, the Department shall make the form easily accessible on
its Internet Web site, in a format that can be downloaded or copied. At a
minimum, the official voluntary nonopioid advance directive form shall include
fields for all of the following:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>The name of the patient.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>An advisory that a patient is not required to have
a form.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The name, telephone number, and signature of the
authorized practitioner authorizing the form.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>The name and contact information of the health
care provider who prepared the form with the patient or the patient's
representative.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Information on who agreed (i.e., the patient or
the patient's representative) to the options selected on the form.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>A range of options for nonopioid prescriptions
and treatment.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>An option to exempt from the nonopioid advance
directive opioids used to treat opioid dependence or other substance use
disorders.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(8)</span></u><span
style='color:black'>        <u>The patient or patient representative's name,
contact information, and signature.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(9)</span></u><span
style='color:black'>        <u>The effective date of the form and any dates the
form is reviewed.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(10)</span></u><span
style='color:black'>      <u>A prominent advisory that directions in an
official voluntary nonopioid advance directive form may suspend, while those
directions are in effect, any conflicting directions in a patient's previously
executed health care power of attorney or other legally authorized instrument.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(11)</span></u><span
style='color:black'>      <u>An advisory that the form may be revoked by the
patient or the patient's representative.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(12)</span></u><span
style='color:black'>      <u>The official voluntary nonopioid advance directive
form shall also include the following statement written in boldface type
directly above the signature line: &quot;You are not required to sign this form
to receive treatment.&quot; The form may be approved by reference to a standard
form that meets the requirements of this subsection.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(e)</span></u><span
style='color:black'>        <u>Immunity for Good&#8209;Faith Compliance. – No authorized
practitioner, emergency medical professional, hospice provider, or other health
care provider shall be subject to criminal prosecution, civil liability, or
disciplinary action by any professional licensing or certification agency for
withholding opioid prescription and treatment from a patient in good&#8209;faith
reliance on an original, official voluntary nonopioid advance directive form
adopted pursuant to subsection (d) of this section, provided that (i) there are
no reasonable grounds for doubting the validity of the form or the identity of
the patient and (ii) the provider does not have actual knowledge of the
revocation of the form.</u></span></p>

<p class=aMargin1><u><span style='color:black'>No authorized practitioner,
emergency medical professional, hospice provider, or other health care provider
shall be subject to criminal prosecution, civil liability, or disciplinary
action by any professional licensing or certification board for failure to
follow an official voluntary nonopioid advance directive form adopted pursuant
to subsection (d) of this section if the provider had no actual knowledge of
the existence of the form.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(f)</span></u><span
style='color:black'>        <u>Civil Liability and Disciplinary Action for
Knowing or Willful Noncompliance. – A knowing or willful failure to comply with
an official voluntary nonopioid advance directive form adopted pursuant to
subsection (d) of this section is a ground for (i) liability in a civil action
for damages suffered as a result of the violation, (ii) disciplinary action by
the appropriate professional licensing or certification board, or (iii) both.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(g)</span></u><span
style='color:black'>        <u>Health Care Facility Policies and Procedures
Regarding Forms. – A health care facility may develop policies and procedures
that authorize the facility's providers to accept a portable official voluntary
nonopioid advance directive form as if it were an order of the medical staff of
that facility. This section does not prohibit an authorized practitioner in a
health care facility from issuing a written order, other than a portable official
voluntary nonopioid advance directive form, to allow a patient to opt not to
receive opioid prescription and treatment or to use, withhold, or withdraw
additional medical interventions as provided in the form, in accordance with
acceptable medical practice and the facility's policies.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(h)</span></u><span
style='color:black'>        <u>Validity of Pre&#8209;Existing Forms. – Nothing
in this section shall affect the validity of a portable voluntary nonopioid
advance directive form in existence prior to the effective date of this
section.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(i)</span></u><span
style='color:black'>         <u>Validity of Forms Originating Outside of North
Carolina. – Notwithstanding any provision of this section to the contrary, a
similar voluntary nonopioid advance directive form originating in a
jurisdiction other than North Carolina is valid in this State if it appears to
have been issued in accordance with the applicable requirements of that
jurisdiction or this State.</u>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 3.(a)</span></b><span
style='color:black'>  By January 1, 2020, the Department of Health and Human
Services shall, in consultation with the North Carolina Board of Medicine and
the North Carolina Board of Pharmacy, (i) develop an official voluntary
nonopioid advance directive form that complies with the requirements of
G.S.&nbsp;90&#8209;21.17A, as enacted by Section 2 of this act, (ii) make the
form easily accessible on its Internet Web site, in a format that can be
downloaded or copied, and (iii) provide notification and a copy of the official
voluntary nonopioid advance directive form to the Commission for Mental Health,
Developmental Disabilities, and Substance Abuse Services.</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 3.(b)</span></b><span
style='color:black'>  This section is effective when it becomes law.</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 4.</span></b><span
style='color:black'>  G.S.&nbsp;130A&#8209;466(a) reads as rewritten:</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><span
style='color:black'>§ 130A&#8209;466.  Filing requirements.</span></p>

<p class=aMargin1><span style='color:black'>(a)        A person may submit any
of the following documents and the revocations of these documents to the
Secretary of State for filing in the Advance Health Care Directive Registry
established pursuant to this Article:</span></p>

<p class=aBlock1><span style='color:black'>…</span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>A voluntary nonopioid advance directive under Article
1B of Chapter 90 of the General Statutes.</u>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 5.</span></b><span
style='color:black'>  Except as otherwise provided, this act becomes effective
January 1, 2020.</span></p>

</div>

</body>

</html>
